secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivani Medical, Inc. (VANI)
CIK:        0001266806
Form:       8-K
Filed at:   2023-07-10T23:59:59+00:00
Accession:  0001753926-23-000914
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivani Medical reincorporates from California to Delaware effective July 5, 2023
--------------------------------------------------------------------------------

- Reincorporation approved at June 15, 2023 Annual Meeting; Plan of Conversion effective July 5, 2023.
- Each California common share converted into one Delaware common share; trading symbol VANI unchanged.
- Stockholder rights now under Delaware law, Certificate of Incorporation, and new Bylaws.
- No change in business, headquarters, management, or jobs; directors and officers continue.
- Authorized capital: 300M shares common ($0.0001 par) and 10M shares undesignated preferred.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1266806/000175392623000914/0001753926-23-000914-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1266806/000175392623000914/g083637_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-23-000914

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer